Please login to the form below

quality of life

This page shows the latest quality of life news and features for those working in and with pharma, biotech and healthcare.

bluebird bio’s beti-cel accepted for priority review by FDA

Togetherthe studies represent more than 220 patient-years of experience, following 63 paediatric, adolescent and adult patients for more than seven years. ... symptoms of anaemia and are associated with serious health risks and reduced quality of

Latest news

Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer

In June, Merck and Eisai also announced that the Keytruda plus Lenvima combination treatment improved outcomes when compared to Pfizer’s Sutent (sunitinib) on a measure of health-related quality of ... life in a phase 3 first-line kidney cancer trial.
Eli Lilly to acquire Protomer Technologies in a deal worth over $1bn

Glucose-sensing insulin is the next frontier and has the potential to revolutionise the treatment and quality of life of people with diabetes by dramatically improving both therapeutic efficacy and safety ... of insulin therapy," said Ruth Gimeno, vice
Researchers publish promising results for ultra-rare disease gene therapy method

to two regions of the midbrain – the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA). ... According to researchers, targeted gene therapy treatment in seven children aged four to nine years old provided ‘dramatic’
Muna raises $73m to advance neurodegenerative disease-focused small molecule pipeline

quality of life for patients as well as caregivers. ... The platform, based on work from the De Strooper and Glerup labs, considers the disease pathology of and resilience to neurodegeneration.
MHRA grants bluebird bio’s LentiGlobin gene therapy an ‘innovation passport’

Sickle cell is a chronic, life-long condition characterised by unpredictable pain crises which can require hospitalisation and have a significant detrimental impact on an individual’s health and quality of ... better quality of life,” he added.

More from news
Approximately 3 fully matching, plus 465 partially matching documents found.

Latest Intelligence

Patient-centred drug development: how far have we come and what’s next?

By Jo Fearnhead-Wymbs. Putting the patient at the centre of clinical development’. ... It simply isn’t always the case. By looking at and even co-creating more innovative quality of life and patient-reported outcome measures, we can do better for
How early-stage clinical research is facilitating the new wave of personalised medicines

The processes and types of therapies trialled have evolved significantly during this period. ... Nevertheless, when successful, it accelerates the development of personalised therapies in order to deliver dramatic improvements in patients’ quality of
Mapping at launch: it’s time to update the satnav

The first 18-24 months of a product’s life cycle are widely considered to be the ‘launch phase’ and a crucial barometer of a brand’s success. ... Patients: the patient journey, entry and exit criteria for starting/stopping therapy, Quality of
AstraZeneca’s focus on diagnosing and managing chronic kidney disease

Finances and job loss, time lost to appointments and dialysis, mental health implications, sleep schedules, planning of life events and dietary changes were all identified as high impact burdens. ... both clinical outcomes and quality of life.
Treatment and prevention of cardiovascular disease

The next generation compounds will build on this evidence base to provide greater efficacy and expanded therapeutic benefits with treatments that are safe, convenient for patients and ultimately improve their quality

More from intelligence
Approximately 1 fully matching, plus 80 partially matching documents found.

Latest appointments

Abeona Therapeutics appoints new additions to board of directors

Its mission to bring relief and an extended, better quality of life to patients, many of whom are children, is closely aligned with my own values, and I am happy to ... I believe Abeona’s pipeline has significant potential to bring transformative
Novimmune expands senior management team

Mylène Fleurant as global head of quality. ... Fleurant joins Novimmune with 20 years of quality expertise in life sciences, most recently having served as head of quality affairs at Alvotech, an Icelandic biosimilars specialist.
Paolo Casati named as general manager of Santen Italy

Casati brings 30 years of management and global business leadership experience in the ophthalmic sector to the role. ... Commenting on his appointment, he said: “Santen group is successful thanks to its commitment to the protection and improvement of
Milestone names chief medical officer

Dr Plat joins from Merck &Co where he was head of atherosclerosis and cardiovascular at the company's Merck Research Laboratories division. ... Dr Plat commented that MSP-2017 promises a “paradigm shift” in the treatment of paroxysmal
Sanofi's Marcoux joins National Public Relations

Marcoux joins the agency from Sanofi, where he was associate vice president of global internal communications and studio production, at the pharma company's Paris headquarters. ... I'm looking forward to helping people better understand the valuable role

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

What does the future hold for Light-chain Amyloidosis?

A prolonged diagnosis. With a protracted and often difficult patient journey, little is still known about the burden of AL amyloidosis on health-related quality of life, because it is a ... and physicians identify treatments and patient support
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day

Many children living with a SWAN will live out their childhood without receiving appropriate treatment that could dramatically improve their quality of life. ... As a company we are devoted to changing lives by helping global life science companies bring
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor

Fishawack Health explores the market and reveals how life science companies can cut through the noise to drive uptake of innovative therapies, including novel TYK2 inhibitors. ... In a disease where the impact on patients’ quality of life has been
Stick or twist? Looking at the patient experience as we emerge from the COVID pandemic

And that alternative fits in with 21st century life in a much better way for many of us. ... Our followers seem bought into these benefits too. When asked about the most significant benefit that remote patient monitoring offers, they overwhelmingly
Remote Patient Monitoring

Incorporating RPM into a patient’s chronic disease management may improve patients’ quality of life, by allowing them to maintain independence, prevent complications, and to minimise personal costs. ... A fundamental role of RPM is to improve the

More from PMHub
Approximately 0 fully matching, plus 87 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

HR Manager – Recruitment/ Generalist combined role, Marketing ag...: circa £50K

Vaccines writer – career opportunity to move into medcomms from ...: Highly competitive salary

Medical Writers > Scientific Directors – Medical Communicatio...: Highly Competitive Salary, Bonus &Benefits

Client Services Director, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Senior Account Exec > CSD – Medical Communications – UK, Lond...: Highly Competitive Salary, Bonus &Benefits

Principal Medical Writer, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Scientific Director, MRNA/ Covid 19, Medical Communications, UK: Six figure salary

B2B media account director: Competitive salary

PMHub

Add my company

Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs: In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?: Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:: Securing a future for telehealth with immersive market research insights...

Email:
Password:

Please login to the form below

quality of life

COVID-19 Updates and Daily News

Featured jobs

Quick links